Quantcast

Latest Erythropoietin Stories

2014-07-21 12:25:25

PORTLAND, Oregon, July 21, 2014 /PRNewswire/ -- A new report by Allied Market Research titled, "Global biosimilars/follow-on-biologics market (types, applications and geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020", suggests that the global biosimilars market would reach $35 billion by 2020 from the estimated $1.3 billion in 2013. Deeper penetration with clearer...

2014-07-03 10:57:32

Society for Experimental Biology Austrian researchers have found that jetlag has severe effects on red blood cells, possibly explaining the high incidence of heart disease seen in shift workers. However, these effects can be counterbalanced by fresh, young red blood cells – making blood donations a potential therapy for shift workers. The scientists, led by Dr Margit Egg (University of Innsbruck), worked on zebrafish (Danio rerio), a model organism which, like humans, is active...

2014-07-02 12:15:29

The JAMA Network Journals In patients with a traumatic brain injury (TBI), neither the administration of the hormone erythropoietin (EPO) or maintaining a higher hemoglobin concentration through blood transfusion resulted in improved neurological outcome at 6 months, according to a study in the July 2 issue of JAMA. Transfusing at higher hemoglobin concentrations was associated with a higher risk of adverse events. Patients with severe traumatic brain injury commonly develop anemia....

2014-06-16 23:04:46

GIA announces the release of a comprehensive global report on Growth Factors (Blood and Tissue) markets. Global market for Growth Factors (Blood and Tissue) is forecast to reach US$48 billion by 2020, driven by growing demand for effective, cost-efficient therapeutics, and increasing significance of growth factors in the treatment of chemotherapy-associated anemia and neutropenia. San Jose, California (PRWEB) June 16, 2014 Follow us on LinkedIn – Fuelled by the growing importance of...

2014-05-21 08:29:46

BOULDER, Colo., May 21, 2014 /PRNewswire/ -- People are individuals. They differ. Patients differ too. Yet, patients with chronic diseases are frequently treated using protocols that ignore patient variability and that have rarely been tested in diverse populations. They do not take into account characteristics that may influence responses to treatment such as age, race, gender, and co-morbid illnesses. Continuous Quality Improvement (CQI) is an iterative, continuing, process used in...

2014-05-20 20:22:02

NEW YORK and BOULDER, Colo., May 20, 2014 /PRNewswire-USNewswire/ -- People are individuals. They differ. Patients differ too. Yet, patients with chronic diseases are frequently treated using protocols that ignore patient variability and that have rarely been tested in diverse populations. They do not take into account characteristics that may influence responses to treatment such as age, race, gender, and co-morbid illnesses. Continuous Quality Improvement (CQI) is an iterative, continuing,...

2014-04-11 12:05:26

Targeting cytomegalovirus may help restore health A virus that is present in most people in a latent state may induce or exacerbate anemia in patients with kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings point to a new therapeutic target for affected individuals. Chronic kidney disease (CKD) patients and kidney transplant recipients often develop anemia, or low levels of red blood cells. This...

2014-04-09 12:30:45

Interest in ZS-9 and Patiromer is High After Review of Respective Product Profiles, According to Findings from Decision Resources Group BURLINGTON, Mass., April 9, 2014 /PRNewswire/ -- Decision Resources Group (DRG) finds that surveyed nephrologists report significant declines in the use of erythropoiesis-stimulating agents (ESAs) in hemodialysis (HD) and peritoneal dialysis, while ESA use in stage 4 use has remained statistically flat and use in stage 3 has increased compared with Q1 2013....

2014-03-28 12:26:15

DUBLIN, March 28, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/8zbxmj/investigation) has announced the addition of the "Investigation Report on China Epoetin Alfa Market, 2009-2018" [http://www.researchandmarkets.com/research/8zbxmj/investigation ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Epoetin alfa refers to erythropoietin (EPO), a hormone-like substance secreted by...

2014-03-11 23:00:21

ChinaMarketResearchReports.com adds Latest Report on “Investigation Report on China Epoetin Alfa Market, 2009-2018” to its store. Dallas, TX (PRWEB) March 12, 2014 Epoetin alfa refers to erythropoietin (EPO), a hormonelike substance secreted by kidney and liver that stimulates erythropoiesis. Indications of EOP approved in China are renal anemia, anemia after chemotherapy and surgery perioperative red blood cell mobilization. The ratio between EPO used in renal dialysis and in...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related